home > bioproject > PRJDB8531
identifier PRJDB8531
type bioproject
sameAs
organism Homo sapiens
title Quantitative detection of ALK fusion breakpoints in plasma cell-free DNA from patients with non-small cell lung cancer using PCR-based target sequencing with a tiling primer set and two-step mapping/alignment
description Tyrosine kinase inhibitors targeted to anaplastic lymphoma kinase (ALK) have been demonstrated to be effective for lung cancer patients with an ALK fusion gene. To detect ALK fusions, because fusion breakpoints occur somewhere in intron 19 of the ALK gene, sequencing of the entire intron is required to locate breakpoints. We constructed a target sequencing system using an adapter and a set of tiling primers that cover the entire ALK intron 19. This system can amplify fragments, including breakpoints, regardless of fusion partners. The data analysis pipeline firstly detected fusions by alignment to selected target sequences, and then quantitated the fusion alleles aligning to the identified breakpoint sequences. The system offers an alternative to existing approaches based on hybridization capture.
data type Targeted Locus (Loci)
publication
properties 
{...}
dbXrefs
sra-run  DRR184337DRR184338DRR184339DRR184340DRR184341DRR184342DRR184343DRR184344DRR184345DRR184346 More
sra-submission  DRA008650
biosample  SAMD00178071SAMD00178072SAMD00178073SAMD00178074SAMD00178075SAMD00178076SAMD00178077SAMD00178078SAMD00178079SAMD00178080 More
sra-study  DRP005398
sra-sample  DRS106860DRS106861DRS106862DRS106863DRS106864DRS106865DRS106866DRS106867DRS106868DRS106869 More
sra-experiment  DRX174818DRX174819DRX174820DRX174821DRX174822DRX174823DRX174824DRX174825DRX174826DRX174827 More
distribution JSONJSON-LD
Download
ddbj_core_bioproject.xml  HTTPS FTP
status public
visibility unrestricted-access
dateCreated 2019-07-08T01:36:20+09:00
dateModified 2019-08-28T13:05:22+09:00
datePublished 2019-08-28T13:05:22+09:00